Skip to main content

Office of National Drug Control Policy

Jump To:

Recent Reports

View More Reports

Open Recommendations (6 total)

Information Management: Selected Agencies Need to Fully Address Federal Electronic Recordkeeping Requirements

GAO-20-59
Show
1 Open Recommendations
Agency Affected Recommendation Status
Office of National Drug Control Policy The Director of the Office of National Drug Control Policy should establish a time frame to ensure, in conjunction with the Office of Administration, that policies and procedures include the (1) following records management controls required for electronic information systems: reliability, context, and structure; and (2) required preservation mechanisms to ensure that records in its electronic recordkeeping system will be retrievable and useable. (Recommendation 28)
Open
The Office of the National Drug Control Policy did not state whether or not it concurred with this recommendation. As of March 2024, we had not received information pertaining to planned actions for this recommendation. Once the office states that it has taken action, we plan to verify whether implementation has occurred.

Information Management: Selected Agencies Need to Fully Address Federal Electronic Recordkeeping Requirements

GAO-20-59
Show
2 Open Recommendations
Agency Affected Recommendation Status
Office of National Drug Control Policy The Director of the Office of National Drug Control Policy should ensure, in conjunction with the Office of Administration, that existing policies and procedures include the required retention and management requirements for email. (Recommendation 29)
Open
The Office of the National Drug Control Policy did not state whether or not it concurred with this recommendation. As of March 2024, we had not received information pertaining to planned actions for this recommendation. Once the office states that it has taken action, we plan to verify whether implementation has occurred.
Office of National Drug Control Policy The Director of the Office of National Drug Control Policy should establish a time frame to develop an inventory of electronic information systems used to store agency records that includes all of the required elements. (Recommendation 27)
Open
The Office of the National Drug Control Policy did not state whether or not it concurred with this recommendation. As of March 2024, we had not received information pertaining to planned actions for this recommendation. Once the office states that it has taken action, we plan to verify whether implementation has occurred.

Drug Control: The Office of National Drug Control Policy Should Develop Key Planning Elements to Meet Statutory Requirements

GAO-20-124
Show
1 Open Recommendations
Agency Affected Recommendation Status
Office of National Drug Control Policy The Director of ONDCP should develop and document key planning elements to help the agency meet the SUPPORT Act requirements to establish a Drug Control Data Dashboard that would include descriptions of resource investments, time frames, and any processes, policies, or roles, and responsibilities needed to address this requirement. (Recommendation 3)
Open
ONDCP provided some information on August 17, 2020 regarding the steps it has taken, and we are awaiting additional documentation for this recommendation. For example, according to ONDCP officials, ONDCP updated the Drug Control Data Dashboard in February 2020 to include enhanced functionality and improved searches. In June 2022, ONDCP officials stated they are in the process of finalizing a directive that addresses planning elements related to the Drug Control Data Dashboard. They expect this directive to be finalized Fall 2022. As of June 2023, ONDCP has not yet provided this document. In February 2024, ONDCP provided us with an update on its efforts to address the recommendation. According to ONDCP officials, ONDCP has started the process of drafting a directive related to the Drug Control Data Dashboard and it should satisfy/address the recommendation. However, ONDCP officials stated that the agency has delayed finalizing the directive in order to focus its effort(s) on drafting and issuing the 2024 National Drug Control Strategy, which is currently in the interagency clearance process, as of February 2024. The ONDCP officials said that once the Strategy is cleared, which the officials hope will be soon, the agency plans to focus on finalizing the directive related to the Drug Control Data Dashboard. ONDCP expects to finalize the directive by end of calendar year 2024.

Drug Control: The Office of National Drug Control Policy Should Develop Key Planning Elements to Meet Statutory Requirements

GAO-20-124
Show
2 Open Recommendations
Agency Affected Recommendation Status
Office of National Drug Control Policy The Director of ONDCP should—after developing and documenting key planning elements—implement an approach, based on these planning elements, to meet the SUPPORT Act requirements to establish a Drug Control Data Dashboard. (Recommendation 4)
Open
ONDCP provided some information on August 17, 2020 regarding the steps it has taken, and we are awaiting additional documentation for this recommendation. For example, according to ONDCP officials, ONDCP updated the Drug Control Data Dashboard in February 2020 to include enhanced functionality and improved searches. In June 2022, ONDCP officials stated they are in the process of finalizing the directive that addresses planning elements related to the Drug Control Data Dashboard. They expect this directive to be finalized Fall 2022. As of June 2023, ONDCP has not yet provided this document. In order to address this recommendation, ONDCP will need to provide the planning document described in Recommendation 3, and show documentation that this document was used to ensure the statutory requirements for the Drug Control Data Dashboard are fulfilled. In February 2024, ONDCP provided us with an update on its efforts to address the recommendation. According to ONDCP officials, ONDCP has started the process of drafting a directive related to the Drug Control Data Dashboard and it should satisfy/address the recommendation. However, ONDCP officials stated that the agency has delayed finalizing the directive in order to focus its effort(s) on drafting and issuing the 2024 National Drug Control Strategy, which is currently in the interagency clearance process, as of February 2024. The ONDCP officials said that once the Strategy is cleared, which the officials hope will be soon, the agency plans to focus on finalizing the directive related to the Drug Control Data Dashboard. ONDCP expects to finalize the directive by end of calendar year 2024.
Office of National Drug Control Policy The Director of ONDCP should—after developing and documenting key planning elements to meet the SUPPORT Act requirements—routinely implement an approach, based on these planning elements, to meet the requirements for the 2020 National Drug Control Strategy and future Strategy iterations. (Recommendation 2)
Open
In June 2021, ONDCP officials provided documentation of internal guidance that includes key planning elements, as discussed in our update to recommendation 1. In order to address this recommendation, ONDCP will need to use this internal guidance to develop future iterations of the National Drug Control Strategy. In April 2022, ONDCP released its 2022 National Drug Control Strategy, and in May 2023, ONDCP issued related documents intended to address remaining statutory requirements for the 2022 strategy, however some of these documents were provided well after the required issuance date for the strategy (February 2022) and after the date that ONDCP informed Congress that the strategy would be completed. In May 2023, ONDCP provided an updated planning document for promulgating the 2024 National Drug Control Strategy. In order to address this recommendation, ONDCP will need to use this internal guidance to develop the 2024 National Drug Control Strategy that meets the statutorily required elements, including the timely issuance of the strategy. According to ONDCP officials, as of February 9, 2024, the 2024 National Drug Control Strategy has not been released as statutorily required. The ONDCP officials stated that pursuant to 21 U.S.C. ? 1705(e), the agency has notified Congress that the Strategy would be submitted after the statutory deadline due to unforeseen delays in the interagency clearance process. ONDCP will submit the Strategy to Congress when it clears the interagency review process, according to ONDCP officials.
View More Recommendations